Anti-endothelial cell autoantibodies and soluble markers of endothelial cell dysfunction in systemic lupus erythematosus

45Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

Abstract

Objective. To determine if anti-endothelial cell antibodies (AECA) and plasma markers of endothelial cell function are related to disease severity in systemic lupus erythematosus (SLE). Methods. We measured AECA by human umbilical vein endothelial cell binding, endothelial markers von Willebrand factor, soluble thrombomodulin, and soluble E-selectin by ELISA, and disease severity by SLEDAI and SLICC/ACR in 35 patients with SLE. Results. Despite high levels of IgG AECA (p = 0.001) and von Willebrand factor (p = 0.0007) compared to 21 healthy controls, we found a positive correlafion only between IgG AECA and the SLEDAI index (r = 0.393, p = 0.021). Conclusion. IgG AECA seem to be related to disease activity in SLE, possibly in a pathogenic role. Conversely, plasma markers of endothelial cell damage seem to be an epiphenomenon and may simply be related to excess inflammation.

Cite

CITATION STYLE

APA

Constans, J., Dupuy, R., Blann, A. D., Resplandy, F., Seigneur, M., Renard, M., … Conri, C. (2003). Anti-endothelial cell autoantibodies and soluble markers of endothelial cell dysfunction in systemic lupus erythematosus. Journal of Rheumatology, 30(9), 1963–1966. https://doi.org/10.1136/annrheumdis-2001.156

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free